Cancer of the uterine cervix

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 1, 1998, Pages 47-50

  Elkas, John ^a   Farias Eisner, Robin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; FEMALE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0031952532     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199802000-00009     Document Type: Review

References (14)

1. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: Cervical Cancer, April 1-3, 1996. J Natl Cancer Inst Monogr 1996; 21:viii-xiii. A summary of the recent National Institutes of Health Consensus Development Conference on cervical cancer.
2. Society of Gynecologic Oncologists Medical Practice and Ethics Committee. Cervical cancer. Mgmt Gynecol Cancers 1996; 1(1):19-25.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer Study Group. J Natl Cancer Inst 1995; 87:796-802.
4. Steller MA, Schiller JT. Human papillomavirus immunology and vaccine prospects. J Natl Cancer Inst Monogr 1996; 21:145-148. A thorough review of the current strategies used for the development of therapeutic and/or prophylactic HPV vaccines.
5. Larson AA, Liao S, Stanbridge EJ, Cavenee WK, Hampton GM. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res 1997; 57:4171-4176. This paper demonstrates that multifocal cervical lesions may be genetically related.
6. Frisch M, Glimelius B, van den Brule AJC, Wohlfahrt J, Meijer CJLM, Walboomers JMM, et al. Sexually transmitted infections as a cause of anal cancer. N Engl J Med 1997; 337:1350-1358.
7. Morris M. Management of stage IA cervical carcinoma. J Natl Cancer Inst Monogr 1996; 21:47-52. This paper reviews current staging and management options for microinvasive cervical cancer.
8. Maiman M, Fruchter RG, DiMaio TM, Boyce JG. Superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol 1988; 72:399-403.
9. Hatch KD, Halum AV, Nour M. New surgical approaches to treatment of cervical cancer. J Natl Cancer Inst Monogr 1996; 21:71-75.
10. Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995; 274:387-393.
11. Sardi JE, Giaroli A, Sananer C, Gerreiera M, Soderini A, Bermudez A, et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997; 67:61-69. This recent publication addresses the benefits of neoadjuvant chemotherapy in stage IB2 patients.
12. Magrina JF. Primary surgery for stage IB-IIA cervical cancer, including short-term and long-term morbidity and treatment in pregnancy. J Natl Cancer Inst Monogr 1996; 21:53-59.
13. Keys H, Gibbons SK. Optimal management of locally advanced cervical carcinoma. J Natl Cancer Inst Monogr 1996; 21:89-92.
14. Hamada K, Alemany R, Zhang W, Hittelman WN, Lotan R, Roth JA, Mitchell MF. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res 1996; 56:3047-3054. This publication demonstrates the potential for gene therapy in cancer of the cervix.